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Abstract 
 The objective of the study was to investigate the effect of Consciousness Energy Healing based DMEM 
medium on the level of alkaline phosphatase enzyme (ALP) activity in Ishikawa cells. The test item, DMEM 
medium was divided into two parts. One part of the test item received Consciousness Energy Healing Treatment 
by a renowned Biofield Energy Healer, Mahendra Kumar Trivedi and was labeled as the Biofield Energy Treated 
DMEM, while the other part did not receive any treatment, and defined as the untreated DMEM group. The cell 
viability using MTT assay of the Biofield Energy Treated DMEM group was observed as 108%, which indicated 
that the test item was safe and non-toxic. The estrogenic potential using ALP level showed a significantly 
increase by 73.21% in the Biofield Energy Treated DMEM group as compared to the untreated DMEM group. 
Overall, the experimental data suggested that the Biofield Energy Treated DMEM has significantly improved ALP 
level, which play a vital role for the promotion and maintenance of estrogen level. Based on the study outcomes, 
it is concluded that Biofield Energy Healing Treatment showed a significant improved ALP level, which can be 
used in various estrogenic disorders such as hypophosphatasia, osteoporosis, severe anemia, malnutrition, 
hypothyroidism, magnesium deficiency, heart surgery, aplastic anemia, chronic myelogenous leukemia, enteritis 
in children, Wilson’s disease, pernicious anemia, bacterial infection and intrauterine infection is a leading cause 
of pelvic inflammatory disease, subfertility, infertility, endometritis, early pregnancy loss, fetal defects, and 
preterm birth. 
DOI : 10.14302/issn.2381-862X.jwrh-18-2459 
Corresponding author: Snehasis Jana, Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, India.                             
Email: publication@trivedisrl.com  
Keywords: Biofield Energy, ALP, Estrogenic potential, Ishikawa cell, DMEM, Menstrual disorder 
Received: Nov 02, 2018                Accepted: Dec 01, 2018                 Published: Dec 03, 2018 
Editor: Manjubala Dash, Mother Theresa Postgraduate & Research Institute of Health Sciences, Pondicherry, 
605006, India. 
In Vitro Assessment of Estrogenic Potential of Biofield Energy Treatment using Human Endometrial 
Adenocarcinoma Cell Line 
  
Freely Available  Online 
www.openaccesspub.org  |  JWRH    CC-license    DOI : 10.14302/issn.2381-862X.jwrh-18-2459         Vol-2 Issue 2 Pg. no.-  13  
 Introduction 
 Alkaline phosphatase (ALP) activity is found in 
high concentration in the endometrium region of 
menstruating women. ALP activity alters during the 
various proliferative phases and supposed to be high in 
early proliferative phase, while it reached the plateau 
during ovulation. Prior to menstruation, the activity of 
enzyme is not detectable in the epithelium and is 
abundant in the vascular endometrium [1]. Thus, ALP 
has significant role in cellular growth, maintaining the 
endocrine function, osteoblastic differentiation, and play 
significant role against many disorders such as human 
breast cancer [2]. Alkaline phosphatases (ALPs) are the 
zinc-containing metalloenzymes plasma membrane-bound 
glycoproteins, which are widely distributed in nature [3]. They 
functions as dimeric molecules and encoded by a 
multigene family and have three metal ions including 
two Zn2+ and one Mg2+ in the active site for their 
essential enzymatic activity [4]. The altered activity 
pattern of ALP is regulated by the sex hormones, along 
with the epithelial alkaline-phosphatase (e-AP) 
concentration, which is on peak at maximum estrogen 
stimulation. Thus, it was reported that most rapid 
endometrial growth happens at the time of maximum 
ALP concentration, which regulates the proper 
endometrial function. Environment have various factors 
such as natural or synthetic, which have significant 
potential to inhibit the estrogen action and causes its 
functional disruption [5]. 
 Several natural and synthetic chemicals that are 
widely distributed in the environment may have the 
potential to mimic estrogens or inhibit estrogen action, 
resulting in disruption of endocrine functions via 
estrogen receptor (ER) [6]. Thus, in this study Ishikawa 
cells were used to study the effect of Biofield Energy 
Treated DMEM on ALP expression, which is the best 
characterized human endometrial cell lines. Ishikawa 
cells are easy to cultivate and express the most relevant 
steroid receptors i.e. ERα and progesterone receptor 
(PR). In addition, the cell line is derived from human 
endometrium, which plays a significant role in female 
reproductive functions and is a fertility-determining 
factor [7, 8]. Hence, Ishikawa cell line (human 
endometrial adenocarcinoma) was selected as a test 
system for this study. Authors evaluated the in vitro 
effect of the Biofield Energy Treated DMEM medium as a 
test item on estrogenic potential using Ishikawa cell line 
for ALP biomarker.     
 In recent years, Biofield Energy Healing has 
been proven to be an alternative method, which has 
been reported to have significant impact on living 
organisms and non-living materials. Besides, increasing 
demand of Complementary and Alternative Medicine 
(CAM) therapies, Biofield Energy Treatment proofed to 
have significant benefits in various scientific fields. The 
effects of the CAM therapies have great potential, which 
include external qigong, Johrei, Reiki, therapeutic touch, 
yoga, Qi Gong, polarity therapy, Tai Chi, pranic healing, 
deep breathing, chiropractic/osteopathic manipulation, 
guided imagery, meditation, massage, homeopathy, 
hypnotherapy, progressive relaxation, acupressure, 
acupuncture, special diets, relaxation techniques, Rolfing 
structural integration, healing touch, movement therapy, 
pilates, mindfulness, Ayurvedic medicine, traditional 
Chinese herbs and medicines in biological systems both 
in vitro and in vivo [9]. The Trivedi                                  
Effect®-Consciousness Energy Healing Treatment 
contain a putative bioenergy, which is channeled by a 
renowned practitioners from a distance. Biofield Energy 
Healing as a CAM showed a significant results in 
biological studies    [10]. However, the National Center 
for Complementary and Alternative Medicine (NCCAM), 
well-defined Biofield therapies in the subcategory of 
Energy Therapies [11]. The Trivedi Effect®- Conscious-
ness Energy Healing Treatment has been reported with 
significant revolution in the physicochemical properties 
of metals, chemicals, ceramics and polymers [12-14], 
improved agricultural crop yield, productivity, and             
quality [15,16], transformed antimicrobial                       
characteristics [17-19], biotechnology [20, 21], 
improved bioavailability [22-24], skin health [25, 26], 
nutraceuticals [27,28], cancer research [29, 30], bone 
health [31-33],  human health and wellness. 
 On the basis of Biofield Energy Treatment 
outcome, authors in this study evaluates the impact of 
the Biofield Energy Healing Treatment (The Trivedi 
Effect®) on DMEM as test sample for estrogenic 
potential with respect to ALP parameter using standard 
in vitro assay in Ishikawa cells.   
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Material and Methods 
Chemicals and Reagents 
 Naringenin was purchased from Sigma, India. 
Fetal bovine serum (FBS) and Dulbecco's Modified 
Eagle's Medium (DMEM) were purchased from Life 
Technology, USA. Antibiotics solution (penicillin-
streptomycin) was procured from HiMedia, India, while 3- (4, 5-
dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium) (MTT), Direct 
Red 80, and   ethylenediaminetetraacetic acid (EDTA) 
were purchased from Sigma, USA. All the other 
chemicals used in this experiment were analytical grade 
procured from India.  
Cell Culture  
 Ishikawa cell line (human endometrial 
adenocarcinoma) from human endometrial tissue was 
used as test system in the present study. Ishikawa cell 
line was maintained in DMEM growth medium for routine 
culture supplemented with 10% FBS. Growth conditions 
were maintained at 37°C, 5%CO2, and 95% humidity 
and subcultured by trypsinisation followed by splitting 
the cell suspension into fresh flasks and supplementing 
with fresh cell growth medium. Before the start of the 
experiment, the growth medium of near-confluent cells 
was replaced with fresh phenol-free DMEM,            
supplemented with 10% charcoal dextran stripped FBS 
(CD-FBS) and 1% penicillin-streptomycin for 3                 
days [34].  
Experimental Design 
 The experimental groups consisted of group 1 
(G-I) the untreated DMEM. Group 2 (G-II) consisted of 
positive control at non-cytotoxic concentrations. Further, 
group 3 (G-III) included the Biofield Treated DMEM. 
Consciousness Energy Healing Treatment Strategies 
 DMEM as the test item was divided into two 
parts, one part was treated with the Biofield Energy by a 
renowned Biofield Energy Healer (also known as The 
Trivedi Effect®) and coded as the Biofield Energy 
Treated DMEM group, and the other part did not receive 
any sort of treatment and denoted as the untreated 
DMEM group. This Biofield Energy Healing Treatment 
was provided by Mahendra Kumar Trivedi remotely for 
~3 minutes through the Healer’s unique Energy 
Transmission process to the test sample under 
laboratory conditions. Biofield Energy Healer was located 
in the USA, while the test items were located in the 
research laboratory of Dabur Research Foundation, New 
Delhi, India. Biofield Energy healer in this study never 
visited the laboratory in person, nor had any contact 
with the test item (DMEM medium). Further, the control 
group was treated with “sham” healer for comparative 
purposes. The “sham” healer did not have any 
knowledge about the Biofield Energy Treatment. After 
that, the Biofield Energy Treated and untreated samples 
were kept in similar sealed conditions for experimental 
study.  
Identification of Non-cytotoxic Concentration  
 The cell viability was performed by MTT assay in 
human endometrial adenocarcinoma cell line (Ishikawa). 
The cells were counted and plated in 96-well plates at 
the density corresponding to 5 X 103 to 10 X 103 cells/
well/180 µL of cell growth medium. The above cells 
were incubated overnight under growth conditions and 
allowed the cell recovery and exponential growth, which 
were subjected to serum stripping or starvation. The 
cells were treated with the test items (DMEM) and 
positive control. The cells in the above plate(s) were 
incubated for a time point ranging from 24 to 72 hours 
in a CO2 incubator at 37°C, 5% CO2, and 95% humidity. 
Following incubation, the plates were taken out and 20 
µL of 5 mg/mL of MTT solution were added to all the 
wells followed by additional incubation for 3 hours at 
37°C. The supernatant was aspirated and 150 µL of 
DMSO was added to each well to dissolve formazan 
crystals. The absorbance of each well was read at 540 
nm using Synergy HT microplate reader, BioTek, USA 
[35]. The percentage cytotoxicity at each tested 
concentrations of the test substance were calculated 
using the following equation (1): 
% Cytotoxicity = (1-X/R)*100 ----------------------- (1) 
Where, X = Absorbance of treated cells; R = Absorbance 
of untreated cells  
 The percentage cell viability corresponding to 
each treatment was obtained using the following 
equation(2): 
% Cell Viability = 100 - % Cytotoxicity --------------- (2) 
 The concentrations exhibiting ≥70% cell viability 
was considered as non-cytotoxic.  
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Study of Alkaline Phosphatase (ALP) Activity 
 The cells were counted and plated in 96-well 
plates at the density corresponding to 5 X 103 cells/
well/180µL phenol-free DMEM+ 10% CD-FBS. The 
above cells were incubated overnight under growth 
conditions for 48 hours in a CO2 incubator at 37°C, 5% 
CO2, and 95% humidity to allow the cell recovery and 
exponential growth. The above cells were incubated with 
the test samples or positive control for 6 days.            
Re-addition of the test sample or positive control was 
done on day 3. After incubation with the test samples, 
the ALP enzyme activity was determined by monitoring 
the hydrolysis of p-nitrophenyl phosphate to p-
nitrophenol (pNPP). The cells were washed with 1X PBS 
and lysed by freeze-thaw method i.e., incubation at -80°
C for 20 minutes followed by incubation at 37°C for 10 
minutes. Lysates were prepared in 0.1% triton-X. 50µL 
of substrate solution i.e., 10 mM of pNPP in 1M 
diethanolamine and 0.24 mM magnesium chloride 
(MgCl2) solution, pH 10.4 was added to all the wells 
containing 50 µL of lysates followed by incubation for 1 
hour at 37°C. The absorbance of the above solution was 
recorded at 405 nm using Synergy HT microplate reader. 
The percentage increase in ALP enzyme activity with 
respect to the untreated DMEM group was calculated 
using equation (3): 
% Increase = [(X-R)/R)]*100 ----------------------- (3) 
Where, X = Absorbance of cells corresponding to 
positive control and test group 
R = Absorbance of cells corresponding to untreated 
group 
Statistical Analysis 
 All the values were represented as Mean ± SEM 
(standard error of mean) of three independent 
experiments. The statistical analysis was performed 
using SigmaPlot statistical software (v11.0). For two 
groups comparison student’s t-test was used. For 
multiple group comparison, one-way analysis of variance 
(ANOVA) was used followed by post-hoc analysis by 
Dunnett’s test. Statistically significant values were set at 
the level of p≤0.05. 
 
 
Results and Discussion 
Cell Viability Study Using MTT  
 Cell viability data using MTT assay in Ishikawa 
cells treated with different concentrations of           
positive controls and the Biofield Energy Treated and 
untreated test samples are represented in Figure 1. The 
data of MTT assay for cell viability showed in term of 
percentage values. The MTT data showed that the 
Biofield Treated DMEM group was found 108% cell 
viability, while it was 75% to 96% in naringenin (positive 
control) group. Thus, the experimental MTT data 
suggested that the Biofield Energy Treated DMEM was 
found to be safe and nontoxic in the Ishikawa cells. 
Thus, DMEM was used to study the estrogenic potential 
(i.e. ALP activity) of The Trivedi Effect®- Biofield Energy 
Healing in vitro using human endometrial adenocarcino-
ma cell line (Ishikawa).   
Study of Alkaline Phosphatase (ALP) Enzyme Activity  
 ALP activity data showed that the Biofield 
Energy Treated DMEM on Ishikawa cell line and the data 
are presented in Figure 2. The percent ALP in the 
untreated DMEM was found as 11.2%. Moreover, the 
percent ALP was significantly increased by 43.75% and 
200.89% (p≤0.001) in the positive control group 
(naringenin) at 500 and 1000 nM, respectively as 
compared to the untreated DMEM group. Besides, the 
percent ALP was significantly (p≤0.001) increased by 
73.21% in the Biofield Energy Treated DMEM group as 
compared to the untreated DMEM group. Biochemical 
measurement of ALP activity reflects as an index of 
osteoblastic differentiation along with the number of 
cells expressing the enzyme as well as enzyme activity in 
each cell [36]. Besides, estrogen level can modulates the 
growth and expression of ALP in human bone marrow 
stromal cell cultures [37]. Estrogen treatment involved 
either maintained or increased level of the ALP 
expression, which directly regulates promotion or sustain 
the osteoblastic differentiation. Lower level of ALP in 
women might results in serious conditions or diseases 
such as hypophosphatasia, postmenopausal women 
receiving estrogen therapy that is due to the 
osteoporosis, severe anemia, malnutrition,             
hypothyroidism, magnesium deficiency, heart surgery, 
aplastic anemia, chronic myelogenous leukemia, children 
with achondroplasia and cretinism, enteritis in children, 
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Figure 1. Assessment of cell viability using MTT assay of the positive control, naringenin at different 
concentrations and test items, DMEM on Ishikawa cell line. 
Figure 2. Alkaline Phosphatase (ALP) enzyme activity study of the Biofield Energy Treated DMEM on        
Ishikawa cell line. All the values are represented as mean ± SEM of three independent experiments. 
***p≤0.001 vs. untreated DMEM group. 
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Wilson’s disease, pernicious anemia, etc. results in 
significant loss of ALP level [38]. In addition, oral 
contraceptives have been also reported to reduce the 
level of ALP [39]. Thus, Biofield Energy Healing 
Treatment might significantly improve the level of 
transcription of target genes, which results in an 
increased ALP level that leads to a better estrogenic 
potential and osteoblastic differentiation.  
Conclusions 
 Biofield Energy Treatment (The Trivedi Effect®) 
on DMEM was studied to evaluate the estrogenic 
potential and in vitro results showed a significant 
improvement with respect to ALP activity. Cell viability 
data using MTT assay showed a significant improved cell 
viability after Biofield Energy Healing Treatment with 
108% in the Biofield Energy Treated group, while more 
than 75% cell viability was observed in the positive 
control group reflecting that the test sample was found 
as safe and nontoxic. Further, the level of ALP was 
significantly increased by 73.21% in the Biofield Energy 
Treated DMEM group as compared with the untreated 
DMEM group. Thus, the Biofield Energy Treated (The 
Trivedi Effect®) DMEM were found to have a significant 
impact on ALP level, which results in a better estrogenic 
potential and osteoblastic differentiation. Therefore, the 
Consciousness Energy Healing based DMEM might be a 
suitable alternative media for cell growth. It can be 
useful for the management of various estrogenic and 
menstrual disorders viz. Dysmenorrhea with painful 
cramps, Premenstrual Syndrome (PMS), Menorrhagia, 
Oligomenorrhea, Amenorrhea, and Missed periods. Thus, 
Biofield Energy Treatment would be useful to control the 
estrogen balance and thus control overall hormonal 
balance, which can be useful against stress, aging, 
osteoporosis, various bone diseases, cell differentiation, 
could improve cell-to-cell communication, normal cell 
growth, neurotransmission, cell cycling and proliferation, 
hormonal balance, skin health, immune and               
cardiovascular functions. Besides, it control the 
hormonal imbalance, various immune related disease 
conditions such as Hashimoto Thyroiditis, Aplastic 
Anemia, Hepatitis, Diverticulitis, Pernicious Anemia, 
Sjogren Syndrome, Myasthenia Gravis, Parkinson’s 
Disease, Asthma, Graves’ Disease, Dermatomyositis, 
Multiple Sclerosis, Ulcerative Colitis, Alzheimer’s Disease, 
Dermatitis, Irritable Bowel Syndrome, Diabetes, 
Atherosclerosis, Systemic Lupus Erythematosus, stress, 
etc. with a safe therapeutic index to improve overall 
health, and Quality of Life. 
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